Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions. [electronic resource]
Producer: 20110202Description: 436-43 p. digitalISSN:- 1365-2249
- Adult
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Autoantibodies -- blood
- B-Lymphocytes -- drug effects
- Calsequestrin -- immunology
- Chemokine CXCL10 -- blood
- Cytokines -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Graves Ophthalmopathy -- blood
- Humans
- Immunity, Humoral -- drug effects
- Immunologic Factors -- therapeutic use
- Inflammation Mediators -- blood
- Interleukin-6 -- blood
- Male
- Middle Aged
- Receptors, Interleukin-6 -- blood
- Receptors, Thyrotropin -- immunology
- Rituximab
- T-Lymphocytes -- drug effects
- Thyrotropin -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.